# Baltimore Medical System, Inc.

Health Center, MD
Page: https://astrelis.co/providers/health_center/211931  
This twin: https://astrelis.co/providers/health_center/211931.md  
CMS Certification Number (CCN): 211931  
Release: 2321a4fc37a7 (2026-10-22)

## Headline figures (fiscal years on file: 2020 to 2020)

Filings that are not a full fiscal year: FY2020 covers 231 days. These years sit in no comparison pool.

- **Total patients (UDS) (FY2024):** 65,173. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Total visits (all service types) (FY2024):** 180,032. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Service sites (FY2024):** 17. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Uninsured patient share (FY2024):** 16.6%. Illustrative estimate. Definition: https://astrelis.co/methodology#health-center
- **Operating margin (FY2020):** -38.1%. Astrelis calculation. Definition: https://astrelis.co/methodology#health-center
- **Total operating revenue (FY2020):** $52.9M. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Total margin (including nonoperating) (FY2020):** +4.9%. Astrelis calculation. Definition: https://astrelis.co/methodology#health-center

## Audited financial statements (Federal Audit Clearinghouse)

Read from the FAC-11 template of the audited statements: every line, every ratio and every status column print as the template carries them, and no figure is withheld. A report's tie status says whether its statements foot; a ratio's plausibility status says whether it sits inside its possible range; a median of fewer than five values says so. The figures were not audited by Astrelis. Contract: https://astrelis.co/methodology/fqhc-audit-contract

### BALTIMORE MEDICAL SYSTEM, INC., MD

Match to this profile: matched by name (method: name and state).

- FY ending 2024-12-31 (audit year 2024): ties in full; audit as filed https://app.fac.gov/dissemination/summary/2024-12-GSAFAC-0000427217
- FY ending 2023-12-31 (audit year 2023): ties in full; audit as filed https://app.fac.gov/dissemination/summary/2023-12-GSAFAC-0000420325
- FY ending 2022-12-31 (audit year 2022): ties in full; audit as filed https://app.fac.gov/dissemination/summary/2022-12-GSAFAC-0000387873

| Line | FY ending 2024-12-31 | FY ending 2023-12-31 | FY ending 2022-12-31 |
|---|---:|---:|---:|
| cash and investments (current) (Statement of financial position) | 2,927,600 [derived, p.7] | 5,986,644 [derived, p.5] | 18,266,385 [derived, p.5] |
| patient receivables, net (Statement of financial position) | 7,736,529 [derived, p.7] | 12,038,422 [derived, p.5] | 8,520,074 [derived, p.5] |
| grants and other receivables (Statement of financial position) | 3,148,590 [derived, p.7] | 3,750,986 [derived, p.5] | 4,142,255 [derived, p.5] |
| other current assets (Statement of financial position) | 1,114,011 [derived, p.7] | 992,512 [derived, p.5] | 986,406 [derived, p.5] |
| TOTAL CURRENT ASSETS (Statement of financial position) | 14,926,730 [extracted, p.7] | 22,768,564 [extracted, p.5] | 31,915,120 [extracted, p.5] |
| property and equipment, net (Statement of financial position) | 15,618,373 [derived, p.7] | 17,211,002 [derived, p.5] | 15,821,798 [derived, p.5] |
| other long-term assets (Statement of financial position) | 31,624,724 [derived, p.7] | 33,385,215 [derived, p.5] | 6,854,798 [derived, p.5] |
| TOTAL ASSETS (Statement of financial position) | 62,169,827 [extracted, p.7] | 73,364,781 [extracted, p.5] | 54,591,716 [extracted, p.5] |
| payables and accrued expenses (Statement of financial position) | 15,657,228 [derived, p.8] | 10,852,310 [derived, p.6] | 13,353,488 [derived, p.6] |
| deferred revenue (Statement of financial position) | 384,568 [derived, p.8] | 134,920 [derived, p.6] | 858,689 [derived, p.6] |
| current debt and leases (Statement of financial position) | 1,901,556 [derived, p.8] | 2,286,694 [derived, p.6] | 1,303,175 [derived, p.6] |
| other current liabilities (Statement of financial position) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| TOTAL CURRENT LIABILITIES (Statement of financial position) | 17,943,352 [extracted, p.8] | 13,273,924 [extracted, p.6] | 15,515,352 [extracted, p.6] |
| long-term debt and leases (Statement of financial position) | 32,816,963 [derived, p.8] | 34,171,786 [derived, p.6] | 8,556,359 [derived, p.6] |
| other long-term liabilities (Statement of financial position) | 371,861 [derived, p.8] | 532,009 [derived, p.6] | 594,858 [derived, p.6] |
| TOTAL LIABILITIES (Statement of financial position) | 51,132,176 [extracted, p.8] | 47,977,719 [extracted, p.6] | 24,666,569 [extracted, p.6] |
| net assets without donor restrictions (Statement of financial position) | 10,912,806 [derived, p.8] | 25,173,404 [derived, p.6] | 29,925,147 [derived, p.6] |
| net assets with donor restrictions (Statement of financial position) | 124,845 [derived, p.8] | 213,658 [derived, p.6] | absent (not printed, or not read) |
| TOTAL NET ASSETS (Statement of financial position) | 11,037,651 [extracted, p.8] | 25,387,062 [extracted, p.6] | 29,925,147 [extracted, p.6] |
| patient service revenue, net (Statement of activities) | 63,678,054 [derived, p.9] | 58,159,886 [derived, p.7] | 57,914,307 [derived, p.7] |
| pharmacy and 340B revenue (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| federal grants (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| other grants and contracts (Statement of activities) | 20,217,817 [derived, p.9] | 22,844,420 [derived, p.7] | 24,004,495 [derived, p.7] |
| contributions (Statement of activities) | 2,647,497 [derived, p.9] | 2,698,689 [derived, p.7] | 1,752,832 [derived, p.7] |
| other revenue (Statement of activities) | 475,523 [derived, p.9] | 316,827 [derived, p.7] | 7,373,531 [derived, p.7] |
| TOTAL REVENUE AND SUPPORT (Statement of activities) | 87,018,891 [extracted, p.9] | 84,019,822 [extracted, p.7] | 91,045,165 [extracted, p.7] |
| salaries and benefits (Statement of activities) | 38,008,766 [derived, p.9] | 47,189,416 [derived, p.7] | absent (not printed, or not read) |
| supplies and pharmaceuticals (Statement of activities) | 24,952,492 [derived, p.9] | 23,756,702 [derived, p.7] | absent (not printed, or not read) |
| purchased and professional services (Statement of activities) | 36,781,470 [derived, p.9] | 20,485,290 [derived, p.7] | absent (not printed, or not read) |
| occupancy (Statement of activities) | 3,869,060 [derived, p.9] | 4,040,276 [derived, p.7] | absent (not printed, or not read) |
| depreciation and amortization (Statement of activities) | 2,032,076 [derived, p.9] | 1,923,690 [derived, p.7] | absent (not printed, or not read) |
| interest (Statement of activities) | 153,042 [derived, p.9] | 225,332 [derived, p.7] | absent (not printed, or not read) |
| other expenses (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| TOTAL EXPENSES (Statement of activities) | 105,796,906 [extracted, p.9] | 97,620,706 [extracted, p.7] | 95,873,379 [extracted, p.7] |
| OPERATING RESULT (Statement of activities) | -18,778,015 [extracted, p.9] | -13,600,884 [extracted, p.7] | -4,828,214 [extracted, p.7] |
| non-operating and other changes (Statement of activities) | 4,428,604 [derived] | 9,062,799 [derived] | 1,542,629 [derived, p.7] |
| CHANGE IN NET ASSETS (Statement of activities) | -14,349,411 [extracted, p.10] | -4,538,085 [extracted, p.8] | -3,285,585 [extracted, p.7] |
| net assets, beginning (Statement of activities) | 25,387,062 [extracted, p.10] | 29,925,147 [extracted, p.8] | 33,210,732 [extracted, p.7] |
| net assets, end (Statement of activities) | 11,037,651 [extracted, p.10] | 25,387,062 [extracted, p.8] | 29,925,147 [extracted, p.7] |

| Ratio | FY ending 2024-12-31 | FY ending 2023-12-31 | FY ending 2022-12-31 |
|---|---:|---:|---:|
| Days cash on hand | 10 days [plausible] | 23 days [plausible] | absent [not computed] |
| Current ratio | 0.83x [plausible] | 1.72x [plausible] | 2.06x [plausible] |
| Operating margin | -21.6% [plausible] | -16.2% [plausible] | -5.3% [plausible] |
| Total margin | -16.5% [plausible] | -5.4% [plausible] | -3.6% [plausible] |
| Patient revenue share | 73.2% [plausible] | 69.2% [plausible] | 63.6% [plausible] |
| Grant dependency | absent [not computed] | absent [not computed] | absent [not computed] |
| Salaries share | 35.9% [plausible] | 48.3% [plausible] | absent [not computed] |
| Days in patient receivables | 44 days [plausible] | 76 days [plausible] | 54 days [plausible] |
| Debt to net assets | 3.15x [plausible] | 1.44x [plausible] | 0.33x [plausible] |
| Health center award share | absent [not computed] | absent [not computed] | absent [not computed] |

## Sources

HRSA Uniform Data System (awardee level; organization match Verified). CMS HCRIS cost reports, form CMS-224-14, as filed (the Medicare cost-report appendix). Federal Audit Clearinghouse single audits as filed (BALTIMORE MEDICAL SYSTEM, INC.; FAC-11 template snapshot, SRC-FAC-001); the organization match is matched by name.

Methodology: https://astrelis.co/methodology · Data sources: https://astrelis.co/data-sources · Data philosophy: https://astrelis.co/data-philosophy

## Cite this page

Astrelis Atlas, "Baltimore Medical System, Inc.", https://astrelis.co/providers/health_center/211931, release 2321a4fc37a7 (2026-10-22). Figures as filed in the named public sources; not audited by Astrelis.

Figures are as filed in the named public sources. Astrelis is not a CPA firm and performs no audit, review or attestation of any facility.